EAACI and Evermed Launch EAACI Nexus, a Digital Education Platform for Allergy and Immunology Education
Manage episode 498472463 series 3607010
In this episode of Global Economic Press, Alex Brady delves into the intersection of medical education and digital innovation with the launch of EAACI Nexus, a new digital education platform. Developed by the European Academy of Allergy and Clinical Immunology in collaboration with Evermed, EAACI Nexus aims to revolutionize allergy and immunology education for professionals worldwide. Officially launched on June 23, 2025, the platform offers personalized, mobile-accessible content with continuous updates, reflecting EAACI's commitment to advancing lifelong learning in a modern and intuitive way. Dr. Maria Torres, President of EAACI, emphasizes the platform's role in making educational content more accessible and impactful for clinicians at all career stages.
EAACI Nexus consolidates the Academy's valuable resources, including Congress presentations, webinars, and guideline-driven education, into a streamlined experience. With features like Netflix-style navigation, powerful search capabilities, and artificial intelligence-powered content recommendations, the platform helps busy professionals quickly find relevant information. Professor Mohamed Shamji, EAACI Secretary General, highlights the platform as a central hub for knowledge and collaboration, while Bozidar Jovicevic, CEO and Co-Founder of Evermed, underscores the importance of personalized, intuitive learning experiences for time-pressed clinicians. EAACI Nexus is now live, supporting the next generation of medical education. For more information, visit Evermed's website.
724 episodes